Literature DB >> 20072990

Giant cell tumor of the frontal bone in an 18-month-old girl: a case report.

M O Ulu1, H Biceroglu, F Ozlen, B Oz, N Gazioglu.   

Abstract

INTRODUCTION: Giant cell tumors (GCT) are benign, but locally aggressive primary bone neoplasms, that frequently occur in the epiphyses of the long bones. Less than 1% of all GCTs primarily involve the skull where they are preferentially seen in the sphenoid and temporal bones. In the pediatric age group they are exceptionally rare. CASE REPORT: The authors report the management of a GCT involving the frontal bone in an 18-month-old girl. The patient underwent wide surgical excision of the lesion and remains free of clinical and radiological evidence of tumoral recurrence thirty months after treatment.
CONCLUSION: Although rare, GCTs should be taken into consideration as a differential diagnosis of rapidly enlarging cranial mass lesions in pediatric patients. Gross total surgical excision eliminates the potential risks of adjuvant radiotherapy. However, considering the aggressive nature and potential malignancy of these lesions, careful long-term clinical and imaging follow-up is recommended. Copyright Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Year:  2010        PMID: 20072990     DOI: 10.1055/s-0029-1243200

Source DB:  PubMed          Journal:  Cent Eur Neurosurg        ISSN: 1868-4904


  3 in total

1.  Giant cell tumour of the posterior cranial fossa: a case report.

Authors:  Z H Lu; Z W Yao
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Giant cell tumor of the occipital bone: A case report and review of the literature.

Authors:  Gonca Hanedan Uslu; Emine Canyilmaz; Adnan Yöney; Sevdegül Aydin; Asli Sahbaz; Ahmet Sari
Journal:  Oncol Lett       Date:  2014-04-25       Impact factor: 2.967

3.  Giant Cell Tumor of the Frontal Bone Presenting as an Orbital Mass.

Authors:  Peter H Tang; Pradeep Mettu; Amanda C Maltry; Andrew R Harrison; Ali Mokhtarzadeh
Journal:  Ophthalmol Ther       Date:  2017-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.